Cervical Neoplasia Clinical Trial
Official title:
Thermal Imaging for Cervical Cancer Screening and Early Detection
When screening results for cervical premalignant lesions are positive, colposcopy is
recommended. This is highly sensitive screening method. However, specificity of the test is
of low.
Thus, a technology that improves the accuracy of the colposcopic exam is needed.
This is a feasibility study with the goal of examining the performance of a thermal imaging
camera in the detection of cervical malignant and premalignant lesions.
n/a
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00702208 -
Feasibility of Delphi Screener for Cervical Cytology
|
Phase 2 | |
| Completed |
NCT02253719 -
Cervical Cancer Screening in HIV Positive and Negative Women in Cambodia
|
N/A | |
| Completed |
NCT05211271 -
Evaluating Thermal Ablation in the Treatment of Cervical Neoplasia
|
N/A | |
| Withdrawn |
NCT00503919 -
Measurement of Digital Colposcopy for Fluorescence Spectroscopy of TNC Using a Second Device
|
Phase 1 | |
| Terminated |
NCT00342173 -
Costa Rican Natural History Study of HPV and Cervical Neoplasia
|
||
| Completed |
NCT00435214 -
Human Papillomavirus (HPV) and Risk of Cervical Precancer and Cancer
|
||
| Completed |
NCT01086709 -
Crossover Vaccination of Women Previously Randomized Into Protocol 04-C-N191
|
||
| Completed |
NCT00766701 -
Spectroscopic Evaluation of Cervical Neoplasia
|
N/A | |
| Completed |
NCT00456807 -
Complementary Testing to Evaluate Immunogenicity of Human Papillomavirus (HPV) Vaccine (580299) in Healthy Female Subjects Aged >/= 26 Years
|
Phase 3 |